The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes

This publication has 35 references indexed in Scilit:

• Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia
  Blood, 2002
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
  Cancer Cell, 2002
• Childhood acute lymphoblastic leukaemia – current status and future perspectives
  The Lancet Oncology, 2001
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995
  Leukemia, 2000
• Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
  Science, 1999
• Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
  The Lancet, 1998
• Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1998
• Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables
  British Journal of Haematology, 1998
• Early response to therapy and outcome in childhood acute lymphoblastic leukemia
  Cancer, 1997
• Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia
  The Lancet, 1991